First published online August 16, 2007
Stem Cells
Vol. 25 No.
11
November 2007, pp.
2874
-2885
doi:10.1634/stemcells.2007-0326; www.StemCells.com
© 2007 AlphaMed Press
TISSUE-SPECIFIC STEM CELLS |
Spinal GABAergic Transplants Attenuate Mechanical Allodynia in a Rat Model of Neuropathic Pain
Karim Mukhidaa,
Ivar Mendeza,
Marcus McLeoda,
Nao Kobayashia,
Christopher Haughna,
Brian Milneb,
Behnam Baghbaderanic,
Arindom Senc,
Leo A. Behiec,
Murray Honga,b
aCell Restoration Laboratory, Departments of Anatomy and Neurobiology and Surgery (Neurosurgery), Dalhousie University, Halifax, Nova Scotia, Canada;
bDepartment of Anaesthesia, Queen's University, Kingston, Ontario, Canada;
cPharmaceutical Production Research Facility, Schulich School of Engineering, University of Calgary, Calgary, Alberta, Canada
Key Words. Neural precursor cell • Transplantation • Pain • Inhibition
Correspondence: Ivar Mendez, M.D., Ph.D., Division of Neurosurgery, Queen Elizabeth II Health Sciences Centre, Room 3806, 1796 Summer Street, Halifax, Nova Scotia B3H 4H7, Canada. Telephone: 902-473-7046; Fax: 902-473-3343; e-mail: mendez{at}dal.ca
Received May 1, 2007;
accepted for publication July 31, 2007.
First published online in STEM CELLS EXPRESS August 16, 2007.
Injury to the spinal cord or peripheral nerves can lead to the development of allodynia due to the loss of inhibitory tone involved in spinal sensory function. The potential of intraspinal transplants of GABAergic cells to restore inhibitory tone and thus decrease pain behaviors in a rat model of neuropathic pain was investigated. Allodynia of the left hind paw was induced in rats by unilateral L5– 6 spinal nerve root ligation. Mechanical sensitivity was assessed using von Frey filaments. Postinjury, transgenic fetal green fluorescent protein mouse GABAergic cells or human neural precursor cells (HNPCs) expanded in suspension bioreactors and differentiated into a GABAergic phenotype were transplanted into the spinal cord. Control rats received undifferentiated HNPCs or cell suspension medium only. Animals that received either fetal mouse GABAergic cell or differentiated GABAergic HNPC intraspinal transplants demonstrated a significant increase in paw withdrawal thresholds at 1 week post-transplantation that was sustained for 6 weeks. Transplanted fetal mouse GABAergic cells demonstrated immunoreactivity for glutamic acid decarboxylase and GABA that colocalized with green fluorescent protein. Intraspinally transplanted differentiated GABAergic HNPCs demonstrated immunoreactivity for GABA and β-III tubulin. In contrast, intraspinal transplantation of undifferentiated HNPCs, which predominantly differentiated into astrocytes, or cell suspension medium did not affect any behavioral recovery. Intraspinally transplanted GABAergic cells can reduce allodynia in a rat model of neuropathic pain. In addition, HNPCs expanded in a standardized fashion in suspension bioreactors and differentiated into a GABAergic phenotype may be an alternative to fetal cells for cell-based therapies to treat chronic pain syndromes.
Disclosure of potential conflicts of interest is found at the end of this article.

Copyright © 2007 by AlphaMed Press.